从Ligustri Lucidi Fructus中捕获基于组件重组策略的优质抗骨质疏松创新的多组件复合物
Jun Jiang1, Baixiu Zhao1, Yuwen Ma1
1School of Pharmacy, Jiangsu University, 301# Xuefu Road, Zhenjiang 212013, Jiangsu Province, China.
概括
这项研究优化了Ligustri Lucidi Fructus (FLL) 成分 (FLLC) 通过改善矿物代谢来治疗绝经后骨质疏松症 (PMOP). 增强的FLLC配方在通过PTH1R/PKA通路逆转骨损失和矿物质失衡方面表现出卓越的疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 骨质疏松症研究 骨质疏松症研究
- 自然产品化学 自然产品化学
背景情况:
- 绝经后的骨质疏松症 (PMOP) 与铁过载和矿物代谢 (,,) 失调有关.
- 红果 (FLL) 显示出双向矿物修复的潜力,但其活性成分和机制尚不清楚.
- 在FLL中的成分比率影响其抗骨质疏松作用.
研究的目的:
- 通过组分重组策略,确定一种最佳的FLL成分 (FLLC) 来治疗PMOP.
- 阐明FLLC双向修复矿物代谢的机制.
主要方法:
- 组件分析的HPLC-DAD和硫酸-安龙方法.
- 斑马鱼和老鼠模型用于药理查和机制阐明.
- 转录组学,分子对接和西布洛特分析以调查PTH1R/PKA通路.
- 正角实验设计以优化FLLC组成.
主要成果:
- 一个优化的FLLC (95%和70%的乙醇提取物以1:12的比例) 显示出优异的抗PMOP活性.
- FLL组件协同促进骨矿化 (CI <1).
- 通过PTH1R/PKA通路,FLLC增强了骨矿物质密度 (BMD),改善了骨微结构,并通过PTH1R/PKA通路平衡了矿物质代谢,增加了PTH1R,cAMP,p-PKA和BMP2,同时降低了SOST.
结论:
- 优化的FLLC有效地逆转矿物代谢障碍,并通过PTH1R/PKA通路增强抗PMOP活性.
- 组件重组策略显著提高了FLL的治疗潜力.
- 这种方法表明,优化天然产品配方可以超过它们的原始疗效.
相关概念视频
Essential Minerals for Bone Health
4.4K
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
4.4K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Hormones and Bone Tissue
2.9K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.9K
Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K


